Company
Headquarters: Mesa, AZ, United States
CEO: Mr. Douglas Ridley
$115,550
USD as of July 1, 2022
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Avidus Management Group Inc. develops, acquires, and operates direct sales and network marketing companies in the consumer health and wellness market in the United States. The company also offers nutraceuticals and health aids; customized nutritional, diet, and exercise plans; and various supplements comprising natural ingredients. The company's principal products include RealW8, a weight loss supplement; and IS2, a functional beverage that supports the body's natural ability to protect, fight, and rebuild against the effects of injuries, illnesses, and diseases. Avidus Management Group Inc. provides its products to various retail vendors, individuals, and businesses. The company was formerly known as Asantae Holdings International Inc. and changed its name to Avidus Management Group Inc. in May 2013. Avidus Management Group Inc. was incorporated in 2006 and is headquartered in Mesa, Arizona.
Top 1-year algo backtest: +313.24%
$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Avidus Management Group, Inc. has the following listings and related stock indices.
Stock: OTC: ASNHF wb_incandescent
Headquarters:
10153 East Hampton Avenue
Suite 101
Mesa, AZ 85209
United States
Phone: 480-278-8712